Practice_tools_and_tips - Articles - Page 4

Using Caution While Prescribing Opioids for Pain

May 1, 2018

Amy Bohnert, PhD Associate professor of psychiatry at the University of Michigan, Investigator at The Center for Clinical Management Research, Department of Veterans Affairs, Ann Arbor, MI Dr. Bohnert has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dosages matter. The risk of death from an overdose with patients prescribed at least 100 mg daily morphine equivalent is about 7 times higher than a patient prescribed less than 20 mg of morphine a day.

Differentiating ADHD From Anxiety: Tips for Clinicians

March 1, 2018

Paula Jurczak, BSW and Joshua Feder, MD

Paula Jurczak, BSW Child and family therapist. Joshua Feder, MD Editor-in-chief, The Carlat Child Psychiatry Report. Ms. Jurczak and Dr. Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When parents bring in their kids for concentration, attention, and learning issues, it’s common to assume a provisional diagnosis of ADHD. In many children, however, anxiety can be the real cause of these problems.

Clozapine: A Fresh Look

March 1, 2018

For those reluctant to make clozapine their go-to antipsychotic for certain patients, this article will provide information to help you decide when it’s right to prescribe.

Abilify MyCite: Patient Care Breakthrough or Patent Extender?

March 1, 2018

You’ve probably heard about a new “digital pill” called Abilify MyCite. The product, which was FDA approved in November 2017, is the first drug in the U.S. with a digital ingestion tracking system.

Prescribing and Managing Antipsychotics

March 1, 2018

Thomas Schwartz, MD

Thomas Schwartz, MD.
Professor and Interim Chair of Psychiatry and Behavioral Sciences, Upstate Medical University, Syracuse, NY. Dr. Schwartz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For those reluctant to make clozapine their go-to antipsychotic for certain patients, this article will provide information to help you decide when it’s right to prescribe.

Lithium: Practical Considerations for Children With Suicidal Thinking

January 1, 2018

Eve Dreyfus, MD and Joshua Feder, MD

Eve Dreyfus, MD Pediatric psychiatrist for Beacon Medical Group Behavioral Health, South Bend, IN Dr. Dreyfus has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. Josh Feder, MD Editor-in-chief of The Carlat Child Psychiatry Report Dr. Feder has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This article covers the judicious consideration and use of lithium in children with suicidal thinking and behavior as part of their overall mental health picture. These challenging situations demand that we stay calm and remain receptive to the frustrations of the family, while at the same time addressing the child’s difficulties.

Helping Clinicians Manage Teen Suicide Risk

January 1, 2018

Cynthia R. Pfeffer, MD

Cynthia R. Pfeffer, MD Professor of psychiatry and director of the Childhood Bereavement Program at Weill Cornell Medicine, White Plains, NY Dr. Pfeffer has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Historically, psychiatrists did not focus on identifying and treating risk factors for child and adolescent suicidal behavior. But after an increase in youth suicide rates in the 1980s, we started doing more research to get clarity about the issues. For example, we became aware that there were clusters of youth committing suicide—doing so in the same community and during the same time period. We suddenly recognized that hearing about a peer committing suicide would raise the risk for that peer’s close friends.

Helping Patients With Stigma and Addiction

January 1, 2018

John F. Kelly, PhD

John F. Kelly, PhD Dr. Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine, Harvard Medical School. He is also founder and director of the Recovery Research Institute, Massachusetts General Hospital. Dr. Kelly has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Stigma is a condition that can be socially discrediting. When it comes to substance use disorders, internalized stigma can lead to feelings of shame. Often, people who suffer from addiction feel discriminated against. People also feel very bad about their behavior, and over time they get more disillusioned with themselves and their own ability to change.

Understanding the Bipolar Spectrum: Tips on Diagnosis

January 1, 2018

Chris Aiken, MD

Chris Aiken, MD

Director of the Mood Treatment Center and instructor at the Wake Forest University School of Medicine. Co-author, with Jim Phelps, of Bipolar, Not So Much (W. W. Norton & Company). Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Aiken discusses the history of bipolar disorder and goes through some key tips on diagnosing bipolar disorder, including the bipolarity index and specific questions to ask patients to help narrow down the diagnosis.

Closing a Practice: Some Practical Suggestions

November 1, 2017

James T. Hilliard, Esq.

James T. Hilliard, Esq. Connor & Hilliard, P.C. Assistant Professor (Legal Medicine), Harvard Medical School, part-time. Mr. Hilliard has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This article offers practical suggestions based on the author’s experiences counseling psychiatrists who are planning for retirement or who have faced unforeseen circumstances causing them to close their practices. Here, we will consider both planned and unplanned retirement scenarios.